Navigation Links
A Once-Daily Oral Drug for Chronic Obstructive Pulmonary Disease That Treats COPD-Related Inflammation Could Achieve Blockbuster Status
Date:2/27/2008

Although Physicians Report Satisfaction with GlaxoSmithKline's Advair and Boehringer Ingelheim/Pfizer's Spiriva, Significant Need Remains for a Novel Anti-Inflammatory Drug, According to a New Report from Decision Resources

WALTHAM, Mass., Feb. 27 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that surveyed physicians indicate that a novel, non- steroidal, anti-inflammatory agent for COPD that improves lung function could capture a significant share of the COPD market by replacing GlaxoSmithKline's Advair (also marketed as Seretide and Adoair).

The new report entitled Chronic Obstructive Pulmonary Disease: Opportunity Lies in Drugs That Address COPD-Related Inflammation finds that an oral, once- daily drug that treats COPD-related inflammation and improves lung function could achieve blockbuster status by 2016. Although an effective anti- inflammatory drug for COPD could replace Advair, it would likely be used in combination with Boehringer Ingelheim/Pfizer's Spiriva, according to the report. Spiriva's efficacy, safety, and convenience make it the current gold standard treatment for COPD but Advair's higher price, longer presence on the market and high prescribing by doctors made Advair the COPD market-share leader in 2006.

The report also finds that, following its approval in 2011 for the indication, Forest Laboratories/Almirall Prodesfarma's aclidinium will become the clinical gold standard for COPD by 2016. Aclidinium, a long-acting muscarinic antagonist (LAMA), will achieve gold standard status by 2016 because of its faster onset of action when compared to Spiriva.

"Because Spiriva is the first-to-market LAMA and has extensive clinical data and physician experience, we don't expect aclidinium to immediately achieve wide acceptance upon launch as the gold standard for COPD as physicians must first gain clinical experience with the d
'/>"/>

SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Labopharms Once-Daily Tramadol Approved in South Korea and Australia
2. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
3. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
4. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
5. ISTA Pharmaceuticals Submits New Drug Application for Xibrom(TM) QD (once-daily)
6. Once-Daily Exjade(R) Shown to Remove Toxic Iron From the Heart and Liver, According to Data Presented at ASH
7. Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
8. Labopharm appeals FDAs decision on once-daily tramadol
9. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
10. Labopharm provides update on U.S. regulatory process for once-daily Tramadol
11. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... The click strand woven bamboo flooring ... the business announces a click strand woven bamboo ... 2015. , Click strand woven bamboo flooring replicates ... well-known brand in the bamboo industry. It promises ... bamboo flooring supplier. , “We are happy to ...
(Date:12/25/2014)... York (PRWEB) December 25, 2014 Product ... DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to ... According to an Order issued in the U.S. District ... Court will convene an open conference on January 7, ... United States Courthouse in West Palm Beach, Florida. The ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online ... its collection of discounted prom dresses, most of which ... spokesman of the company, the promotion is valid until ... to expand the UK market. , The prom dresses ... lengths, and styles: A-line strapless, empire strapless chiffon, one ...
(Date:12/25/2014)... 25, 2014 BambooFlooringChina.com sells many bamboo ... bamboo flooring. Today, the company announces big discounts ... styles and colors. , BambooFlooringChina.com is the world’s leader ... promotion is valid until Jan. 20, 2015. , The ... woven with a natural thread. All the bamboo strips ...
(Date:12/25/2014)... LunaDress.co.uk has updated its blog to provide professional shopping tips on ... models at LunaDress.co.uk come with big discounts, up to 80 percent ... turn out to be a most exciting memory and can show ... surprise to a wedding. On the updated fashion blog, ladies can ... a big day . , Going out with friends to a ...
Breaking Medicine News(10 mins):Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2
... manufacture plentiful anti-flu drugs at a cheaper cost. Tamiflu is ... method while relaxing at home on a weekend. // The ... to World Health Organization to prevent any outbreak of the ... cycle is a compound extracted from the plant star anise. ...
... of the NHS Grampian said that people were offered places ... health board said so defending their decision to house hospital ... ,A spokeswoman for NHS Grampian said a doctor always took ... a patient to stay outwith the city's Royal Infirmary. She ...
... a Hamilton firefighter who died of cancer consequent to battling ... compensation //scheme to firefighters as well. Shaw says it's a ... diseases. ,New Democrat Andrea Horvath has introduced a ... father spent four days fighting the Plastimet fire in July ...
... a hospital in Delhi is said to have performed cochlea ... further claimed that the patient is the youngest to undergo ... Hospital said that the girl from Gurgaon was the youngest ... far. ,"The child was suffering from 90 percent ...
... action by mutations of the virus into a human flu strain, ... plan of action can we rely on to control the spread? ... are teaming up next month to roll out a mock drill ... pandemic. ,Australia and Singapore will be co-coordinating the exercise, ...
... new clinical development partnership being launched by the ... Research Technology (CRT) plans to take up// drug ... showing enough commercial promise following their preclinical studies. ... from anti-cancer drugs that have been shelved by ...
Cached Medicine News:Health News:Cancer Research UK Offers New Hope To Cancer Patients 2
(Date:12/24/2014)...   Synageva BioPharma Corp. (NASDAQ: ... products for rare disorders, today announced validation by ... Authorization Application (MAA) for sebelipase alfa for LAL ... for accelerated assessment, which has the potential to ... The MAA, and the Biologics License Application ...
(Date:12/24/2014)... , Dec. 23, 2014  Lockton Dunning ... of Lockton Companies, announced the addition of Vice ... will join Lockton Dunning,s Pharmacy Consulting team, Excelsior ... of relevant industry experience to the position.  Most ... Market Sales at Diplomat Specialty Pharmacy, where she ...
(Date:12/24/2014)... , Dec. 23, 2014 Tianyin Pharmaceutical ... that specializes in patented biopharmaceutical, modernized traditional Chinese ... (API) today announced that the Company achieved the ... Manufacturing Practice (GMP) certificate of TPI,s Qionglai Facility ... (CFDA). The public notice period is a significant ...
Breaking Medicine Technology:Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3Kim Foerster Joins Lockton Companies 2TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3
... Oct. 27 According to Millennium Research Group ... intelligence, the European arthroscope market generated over $30 ... over 2009 due to decreasing scope prices and ... Due to unfavorable economic conditions, manufacturers are ...
... today announced that it has received approval from the ... (US 7,815,929) regarding a method for the preparation, storage ... very nature, the process of compounding suppositories is cumbersome, ... Indu Muni, founder, chairman, and CEO of CutisPharma, Inc. ...
Cached Medicine Technology:Despite Rising Procedure Volumes, the $30 Million European Arthroscope Market Experienced Nominal Growth in 2010 2Despite Rising Procedure Volumes, the $30 Million European Arthroscope Market Experienced Nominal Growth in 2010 3CutisPharma Announces Issuance of an Additional Patent for Suppository Compounding 2
Facilitates one-lung ventilation when using dual lumen endobronchial tubes....
... Double lumen tubes ... ventilation., ,Each ... is packaged with ... adaptors, suction catheters ...
... double lumen tube made of silicone rubber with ... to the characteristics of silicone rubber, Silbronco is ... insertion. Furthermore, the tube will not soften like ... term surgery., ,Silbronco is also especially useful ...
Used for endobronchial blockade of the left or right lung for procedures which require one-lung ventilation. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: